Aurora Vega-Paez
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Impact of CMV-specific immune reconstitution at the end of letermovir prophylaxis on the development of late cytomegalovirus infection in haematopoietic stem cell transplant recipients (INMUNOEND): a protocol for a prospective, observational, multicentre study.
Journal: BMJ open
Published: October 15, 2025
Quantifying Gamma-Interferon from CMV-Specific CD8+ T Cells Defines Protection Against Clinically Significant CMV Infection in Solid Organ Transplant Recipients: The Quanti-CMV Score.
Journal: Microorganisms
Published: February 16, 2025
Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3, noninferiority trial.
Journal: The Lancet regional health. Europe
Published: August 29, 2024
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.
Journal: Transplantation reviews (Orlando, Fla.)
Published: July 08, 2024
Real-life experience in two cases of secondary prophylaxis with letermovir for CMV infection in solid organ transplantation.
Journal: Microbiology spectrum
Published: October 30, 2023
QuantiFERON-CMV assay by chemiluminescence immunoassay: Is it more suitable for real-live monitoring of transplant patients?
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: October 19, 2023
Memory SARS-CoV-2 T-cell response in convalescent COVID-19 patients with undetectable specific IgG antibodies: a comparative study.
Journal: Frontiers in immunology
Published: January 12, 2023
Humoral/Cellular Immune Discordance in Stem Cell Donors: Impact on Cytomegalovirus-Specific Immune Reconstitution after Related Hematopoietic Transplantation.
Journal: Transplantation and cellular therapy
Published: March 10, 2022
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 17, 2021
Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation.
Journal: The Journal of infectious diseases
Published: May 27, 2020
Adherence to Human Colon Cells by Multidrug Resistant Enterobacterales Strains Isolated From Solid Organ Transplant Recipients With a Focus on Citrobacter freundii.
Journal: Frontiers in cellular and infection microbiology
Published: May 08, 2020
Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact.
Journal: Scientific reports
Published: December 19, 2019
Last Updated: 09/26/2026